Symbiotec Pharmalab Limited proposes to open the Bid / Offer Period in relation to its Initial Public Offer of the Equity Shares on Monday, August 24, 2026. The Offer comprises a fresh issue of such number of Equity Shares by the Company aggregating up to ₹1,500.00 million and offer for sale of up to ₹16,070.00 million by certain existing shareholders of the Company.
- Issue Opens: August 24, 2026
- Issue Closes: August 27, 2026
- Face Value: Rs 2
- Price Band: Rs 938 – 988 per share
- Minimum Bid Lot: 15 Equity Shares
- Listing: BSE & NSE
The Price Band of the Offer has been fixed at ₹938 to ₹988 per Equity Share. Bids can be made for a minimum of 15 Equity Shares and in multiples of 15 Equity Shares thereafter. Discount Of ₹ 90.00 Per Equity Share of Face Value of ₹2 is being offered to Eligible Employees Bidding in the Employee Reservation Portion. The Anchor Investor Bid/Offer Period opens and closes on Friday, August 21, 2026. The Bid/Offer Period will open on Monday, August 24, 2026, for subscription and close on Thursday, August 27, 2026. The Equity Shares to be listed on BSE and NSE.
The Company proposes to utilise the Net Proceeds towards Prepayment and/or repayment, in full or in part, of all or a portion of certain outstanding borrowings availed by the Company; and General corporate purposes.
The Offer for Sale comprises such number of Equity Shares aggregating up to ₹1,440.00 million by Satwani Holdings LLP, such number of Equity Shares aggregating up to ₹9,880.00 million by Rosewood Investments, and such number of Equity Shares aggregating up to ₹4,750.00 million by India Business Excellence Fund – III.
